Interfacial Effects Enable Droplet Actuation, Inhibition Relief, and Early Sensing of Polymerase Chain Reaction (UA15-071)

This technology is a device and associated methods that improve quantitative real-time polymerase chain reaction (qPCR) by allowing detection of PCR amplification and quantification of initial target amount to occur at an earlier amplification cycle. This innovation is possible through the novel utilization of interfacial effects in PCR reaction droplets. Ultimately this allows for faster results and more informed medical decision-making in point-of-care settings and has potential for COVID-19 testing applications.Background:Quantitative real-time polymerase chain reaction (qPCR) is a method of detecting DNA amplified via the polymerase chain reaction (PCR) in real time, rather than after the completion of the amplification reaction. qPCR is useful in point-of-care diagnosis of certain diseases and conditions. However, current qPCR methods (e.g. fluorescence detection) still require a high number of amplification cycles before detection and quantification are possible. Improvements that allow PCR detection and quantification to take place at an earlier amplification cycle take less time and enable healthcare providers to make faster decisions in point-of-care settings.Learn more at Anne Spieth 520-626-1577

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More